Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Jinwei Lei"'
Autor:
Qiulin Wu, Guobing Yin, Jing Luo, Yingzi Zhang, Tiantian Ai, Jiao Tian, Yudi Jin, Jinwei Lei, Shengchun Liu
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundHepatocyte growth factor (HGF) signaling plays a plethora of roles in tumorigenesis and progression in many cancer types. As HGF activator inhibitors, serine protease inhibitor, Kunitz types 1 and 2 (SPINT1 and SPINT2) have been reported to
Externí odkaz:
https://doaj.org/article/df8018e6d8eb4a4db2fc08cf25bc13fe
Publikováno v:
Frontiers in Molecular Biosciences, Vol 7 (2020)
Background: KLHL5 (Kelch Like Family Member 5) is differentially expressed in gastric cancer, but its correlation with prognosis and functioning mechanism in gastric cancer remain unclear.Methods: The Oncomine database and TIMER were employed to appr
Externí odkaz:
https://doaj.org/article/0b8c3045606c4a11949908c04f4a5296
Autor:
T Ai, Shipeng Guo, Ying Zhang, Jinwei Lei, Beige Zong, Yang Peng, Kang Li, Shengchun Liu, Jiao Tian
Publikováno v:
Clinical and Translational Oncology. 24:503-516
Purpose Lysophosphatidic acid (LPA) is a bioactive molecule which participates in many physical and pathological processes. Although LPA receptor 6 (LPAR6), the last identified LPA receptor, has been reported to have diverse effects in multiple cance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ecd66dcba540fce76de68b49ab5c736
https://doi.org/10.1007/s12094-021-02704-8
https://doi.org/10.1007/s12094-021-02704-8
Autor:
Yingkun Xu, Yang Peng, Meiying Shen, Li Liu, Jinwei Lei, Shun Gao, Yuan Wang, Ailin Lan, Han Li, Shengchun Liu
Publikováno v:
Journal of Oncology.
This study is aimed at exploring the potential mechanism of angiogenesis, a biological process-related gene in breast cancer (BRCA), and constructing a risk model related to the prognosis of BRCA patients. We used multiple bioinformatics databases an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d0f15fb073feeab7a77e740da47dd11
Autor:
Jinwei Lei, Lu Sun, Shengchun Liu, Shipeng Guo, Yang Peng, Kang Li, Yu Yu, Yingzi Zhang, Beige Zong, Yihua Wang
Publikováno v:
Oncology Reports. 46
Following the publication of this article, the authors realized that the published version of Fig. 4A contained an erroneous label; essentially, the information purported to relate to experiments having been performed with docetaxel should not have b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d74b10d4cb138c7c52aaa8a1379fe95b
https://doi.org/10.3892/or.2021.8146
https://doi.org/10.3892/or.2021.8146
Autor:
Yu Yu, Lu Sun, Jinwei Lei, Yang Peng, Kang Li, Shipeng Guo, Beige Zong, Yihua Wang, Yingzi Zhang, Shengchun Liu
Publikováno v:
Oncology Reports
HORMA domain-containing protein 1 (HORMAD1), is normally expressed only in the germline, but is frequently re-activated in human triple-negative breast cancer (TNBC); however, its function in TNBC is largely unknown. In the present study, the express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::537fe40c2701e44f28efaaa37738289b
https://doi.org/10.3892/or.2021.8089
https://doi.org/10.3892/or.2021.8089
Autor:
Jinwei Lei, Jing Luo, Yudi Jin, Guobing Yin, Shengchun Liu, Jiao Tian, Qiulin Wu, Yingzi Zhang, Tiantian Ai
Publikováno v:
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundHepatocyte growth factor (HGF) signaling plays a plethora of roles in tumorigenesis and progression in many cancer types. As HGF activator inhibitors, serine protease inhibitor, Kunitz types 1 and 2 (SPINT1 and SPINT2) have been reported to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8008f4373dae405e41c5d707eefac403
https://pubmed.ncbi.nlm.nih.gov/34381422
https://pubmed.ncbi.nlm.nih.gov/34381422
Autor:
Jiao Tian, Yingzi Zhang, Lu Sun, Shengchun Liu, Yang Peng, Beige Zong, Kang Li, Chi Qu, Jinwei Lei
Publikováno v:
Breast Cancer (Tokyo, Japan)
Background Recent studies have indicated that serpin peptidase inhibitor, clade A, member 3 (SERPINA3) is a potential marker associated with tumor progression, which connoted that SERPINA3 is related to malignant phenotypes in cancer. However, the bi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2c19d036547480324105e18d53cd34b
https://pubmed.ncbi.nlm.nih.gov/33569740
https://pubmed.ncbi.nlm.nih.gov/33569740
Autor:
Qiulin Wu, Guobing Yin, Jing Luo, Yingzi Zhang, Tiantian Ai, Jiao Tian, Yudi Jin, Jinwei Lei, Shengchun Liu
Publikováno v:
Frontiers in Endocrinology; 6/26/2022, Vol. 13, p1-16, 16p